The current detection of a relative increase in the proportion of FOXP3 Tregs early after MSC infusion corroborates previous findings of increased relative levels of CD4+CD25+ Tregs at 4 and 24 h after combined IV and IT MSC infusion in MS [17]. The gene discussed is FOXP3; the disease is myeloid sarcoma.